The beta secretase BACE1 regulates the expression of insulin receptor in the liver

Abstract : Insulin receptor (IR) plays a key role in the control of glucose homeostasis; however, the regulation of its cellular expression remains poorly understood. Here we show that the amount of biologically active IR is regulated by the cleavage of its ectodomain, by the β-site amyloid precursor protein cleaving enzyme 1 (BACE1), in a glucose concentration-dependent manner. In vivo studies demonstrate that BACE1 regulates the amount of IR and insulin signaling in the liver. During diabetes, BACE1-dependent cleavage of IR is increased and the amount of IR in the liver is reduced, whereas infusion of a BACE1 inhibitor partially restores liver IR. We suggest the potential use of BACE1 inhibitors to enhance insulin signaling during diabetes. Additionally, we show that plasma levels of cleaved IR reflect IR isoform A expression levels in liver tumors, which prompts us to propose that the measurement of circulating cleaved IR may assist hepatic cancer detection and management.
Complete list of metadatas

Cited literature [64 references]  Display  Hide  Download

https://www.hal.inserm.fr/inserm-01762378
Contributor : Franck Peiretti <>
Submitted on : Friday, October 25, 2019 - 9:43:45 AM
Last modification on : Saturday, October 26, 2019 - 2:00:29 AM

File

s41467-018-03755-2.pdf
Publication funded by an institution

Licence


Distributed under a Creative Commons Attribution 4.0 International License

Identifiers

Citation

Paul Meakin, Anna Mezzapesa, Eva Benabou, Mary Haas, Bernadette Bonardo, et al.. The beta secretase BACE1 regulates the expression of insulin receptor in the liver. Nature Communications, Nature Publishing Group, 2018, 9 (1), ⟨10.1038/s41467-018-03755-2⟩. ⟨inserm-01762378⟩

Share

Metrics

Record views

193

Files downloads

17